Redcliffe Labs announced the launch of the Elecsys\u00ae AMH Plus blood test, in collaboration with Roche Diagnostics India, to support the timely identification of Polycystic Ovarian Morphology (PCOM) and aid in the diagnosis of Polycystic Ovary Syndrome (PCOS).<\/p>\n
Nearly one in five women of reproductive age in India is affected by PCOS. To address this growing concern,\u00a0Redcliffe Labs, through the\u00a0Elecsys\u00ae AMH Plus\u00a0test, is transforming the diagnostic experience. Instead of relying on invasive scans, a simple blood test now measures Anti-M\u00fcllerian Hormone (AMH), a biomarker closely associated with PCOM and found in nearly four out of five PCOS cases in India.<\/p>\n
This innovation replaces the discomfort and limitations of transvaginal ultrasounds (TVUS) with a convenient, reliable solution that offers a minimally invasive test for a patient-friendly diagnosis. The test results are accurate across body types, and it can be performed at any time without waiting for specific menstrual phases.<\/p>\n
The Elecsys\u00ae AMH Plus test is supported by strong global and Indian validation. International guidelines (2023) now recognize AMH as a credible alternative to ultrasound for evaluating PCOM, while in India,\u00a0FOGSI\u2019s Good Clinical Practice Recommendations\u00a0endorse its role in PCOS diagnosis. Large clinical studies such as APHRODITE and HARMONIA confirm its high accuracy, with a 3.2 ng\/mL cutoff, achieving 89% sensitivity and 85% specificity.<\/p>\n
Aditya Kandoi, Founder & CEO of Redcliffe Labs, added: \u201cPCOS remains one of the most widespread yet underdiagnosed health issues for women. With this innovative test, we are breaking diagnostic barriers and enabling timely, accurate care and empowering women through proactive health solutions that redefine their reproductive and metabolic journeys.\u201d\u00a0<\/p>\n
Dr. Rishubh Gupta, MD, Roche Diagnostics India, added,\u00a0\u201cBy introducing the Elecsys\u00ae AMH Plus blood test, Redcliffe Labs is making PCOS diagnostics more accessible and less intimidating. This reinforces our commitment to bridging healthcare gaps by consistently bringing Roche\u2019s world-class clinical innovations to the Indian market.\u201d\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Redcliffe Labs announced the launch of the Elecsys\u00ae AMH Plus blood test, in collaboration with Roche Diagnostics India,…\n","protected":false},"author":2,"featured_media":35540,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[21031,21032,21033,10147,21034,21035,21036,21037,9062,21038,21039,21040,21041,21042,21043,21044,134,21045,16009],"class_list":["post-35539","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-amh-test","tag-anti-mullerian-hormone","tag-aphrodite-study","tag-diagnostic-solutions","tag-elecsys-amh-plus","tag-female-fertility","tag-fogsi","tag-harmonia-study","tag-healthcare-innovation","tag-hormonal-testing","tag-lab-technology","tag-non-invasive-diagnostics","tag-pcom","tag-pcos-diagnosis","tag-redcliffe-labs","tag-reproductive-health","tag-roche","tag-roche-diagnostics-india","tag-womens-health"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116260554933439883","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/35539","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=35539"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/35539\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/35540"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=35539"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=35539"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=35539"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}